We are live on
!
Find out more
Iovance Biotherapeutics
IOVA
IOVA
242 hedge funds and large institutions have $1.45B invested in Iovance Biotherapeutics in 2022 Q3 according to their latest regulatory filings, with 32 funds opening new positions, 82 increasing their positions, 86 reducing their positions, and 26 closing their positions.
New
Increased
Maintained
Reduced
Closed
504% more call options, than puts
Call options by funds: $19.6M | Put options by funds: $3.25M
23% more first-time investments, than exits
New positions opened: 32 | Existing positions closed: 26
2% more funds holding
Funds holding: 237 → 242 (+5)
5% less repeat investments, than reductions
Existing positions increased: 82 | Existing positions reduced: 86
3.63% less ownership
Funds ownership: 101.39% → 97.76% (-3.6%)
15% less capital invested
Capital invested by funds: $1.71B → $1.45B (-$257M)
100% less funds holding in top 10
Funds holding in top 10: 4 → 0 (-4)
Holders
242
Holders Change
+5
Holders Change %
+2.11%
% of All Funds
4.17%
Holding in Top 10
–
Holding in Top 10 Change
-4
Holding in Top 10 Change %
-100%
% of All Funds
–
New
32
Increased
82
Reduced
86
Closed
26
Calls
$19.6M
Puts
$3.25M
Net Calls
+$16.4M
Net Calls Change
+$2.37M
Top Buyers
| 1 |
Goldman Sachs
New York
|
+$12M |
| 2 |
Vanguard Group
Malvern,
Pennsylvania
|
+$10.3M |
| 3 |
Two Sigma Investments
New York
|
+$10.1M |
| 4 |
Renaissance Technologies
New York
|
+$9.33M |
| 5 |
Bank of Montreal
Toronto,
Ontario, Canada
|
+$7.81M |
Top Sellers
| 1 |
FCM
Farallon Capital Management
San Francisco,
California
|
-$35.1M |
| 2 |
Citadel Advisors
Miami,
Florida
|
-$24.1M |
| 3 |
State Street
Boston,
Massachusetts
|
-$21.2M |
| 4 |
PA
Perceptive Advisors
New York
|
-$18.2M |
| 5 |
Invesco
Atlanta,
Georgia
|
-$17.8M |
